|
Market Closed -
NSE India S.E.
15:05:07 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 401.00 INR | -0.01% |
|
-3.88% | +1.80% |
| 08-21 | Mazumdar Shaw's Mission to Expand Access to Vital Drugs | MT |
| 08-06 | Biocon Limited Announces Retirement of Nicholas Robert Haggar as an Independent Director, Effective August 06, 2026 | CI |
| Market Cap | 649B 6.87B 5.93B 5.59B 5.09B 9.51B 9.59B 66.14B 25.67B 332B 25.82B 25.25B 1,091B | P/E 2027 * |
57.7x | P/E 2028 * | 34.5x |
|---|---|---|---|---|---|
| Enterprise Value | 752B 7.96B 6.87B 6.47B 5.9B 11.02B 11.1B 76.6B 29.73B 385B 29.9B 29.24B 1,263B | EV / Sales 2027 * |
3.87x | EV / Sales 2028 * | 3.32x |
| Free-Float |
51.84% | Yield 2027 * |
0.14% | Yield 2028 * | 0.23% |
Last Transcript : Biocon Limited
| 1 day | -0.01% | ||
| 1 week | -3.88% | ||
| Current month | -2.67% | ||
| 1 month | -5.80% | ||
| 3 months | -5.79% | ||
| 6 months | +2.87% | ||
| Current year | +1.80% |
| 1 week | 397.9 |  | 421.6 |
| 1 month | 397.9 | | 442.5 |
| Current year | 337.7 | | 447.15 |
| 1 year | 337.05 | | 447.15 |
| 3 years | 217.5 | | 447.15 |
| 5 years | 191.55 | | 447.15 |
| 10 years | 134.07 | | 487.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Saurabh Paliwal
IRC | Investor Relations Contact | - | - |
Shreehas Tambe
CEO | Chief Executive Officer | - | 01/04/2026 |
Kedar Upadhye
DFI | Director of Finance/CFO | 48 | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 24/04/2014 | |
| Director/Board Member | 71 | 01/01/2000 | |
| Chairman | 73 | 29/11/1978 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | -3.88% | +13.74% | +53.76% | 6.84B | |
| +1.03% | -3.11% | +39.80% | +94.60% | 68.21B | |
| +1.62% | +0.33% | +48.61% | +89.64% | 64.25B | |
| +1.52% | -0.60% | -14.91% | +368.87% | 26.54B | |
| +1.15% | -8.40% | +2.46% | -15.49% | 25.61B | |
| +1.30% | +0.74% | +31.66% | -18.33% | 19.88B | |
| -0.38% | -12.42% | +224.86% | +373.18% | 17.13B | |
| +0.65% | -5.83% | +1.44% | +544.44% | 14.93B | |
| +1.56% | +3.17% | +55.68% | +159.90% | 14.1B | |
| +0.79% | +0.65% | +24.37% | +193.97% | 12.45B | |
| Average | +0.92% | -3.76% | +42.77% | +184.45% | 26.99B | |
| Weighted average by Cap. | +1.13% | -3.03% | +41.46% | +151.14% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 194B 2.06B 1.77B 1.67B 1.52B 2.85B 2.87B 19.78B 7.68B 99.3B 7.72B 7.55B 326B | 223B 2.36B 2.04B 1.92B 1.75B 3.27B 3.29B 22.7B 8.81B 114B 8.86B 8.67B 374B |
| Net income | 11.09B 117M 101M 95.4M 86.92M 162M 164M 1.13B 438M 5.67B 441M 431M 18.62B | 17.45B 185M 159M 150M 137M 256M 258M 1.78B 690M 8.92B 694M 679M 29.31B |
| Net Debt | 103B 1.09B 938M 883M 805M 1.5B 1.52B 10.46B 4.06B 52.5B 4.08B 3.99B 172B | 91.52B 969M 836M 787M 717M 1.34B 1.35B 9.32B 3.62B 46.79B 3.64B 3.56B 154B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | ₹401.00 | -0.01% | 1,433,504 |
| 01/09/26 | ₹401.05 | -2.66% | 2,120,745 |
| 31/08/26 | ₹412.00 | +0.22% | 3,746,419 |
| 28/08/26 | ₹411.10 | -1.74% | 2,187,557 |
| 27/08/26 | ₹418.40 | +0.22% | 1,713,404 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIOCON Stock
Select your edition
All financial news and data tailored to specific country editions
